| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.099 | 0.2 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |